EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of Multistrain Probiotic Supplementation on Glycemic Control in Type 2 Diabetes Mellitus—Randomized Controlled Trial

Venkata Chaithanya iD, Janardanan Kumar iD, Kakithakara Vajravelu Leela, Mohan Ram, Jayaprakash Thulukanam

Life · 14.11.2024 · 14 (11) · 1484

DOI: 10.3390/life14111484 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Life, online erschienen am 14.11.2024. Verfasst von Venkata Chaithanya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, SRM Medical College Hospital and Research Centre, SRMIST, Kattankulathur, Chengalapattu 603203, Tamil Nadu, India. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SRM University, SRM Selective Excellence Research Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperglycemia, a key characteristic of type 2 diabetes mellitus (T2DM), highlights the need for effective management strategies. This study aims to analyze the impact of multistrain probiotic supplementation on glycemic control in T2DM patients. During a 24-week randomized controlled trial involving 130 participants, subjects were assigned to either a probiotic group or a placebo group. The key outcomes included fasting blood glucose (FBG), postprandial blood glucose (PPBG), glycated hemoglobin (HbA1c) levels, and lipid profiles, assessed at baseline and post-intervention. The results indicated a significant reduction in HbA1c (p = 0.004) and increased HDL-c (p = 0.023) and improvements in lipid profiles in the probiotic group, alongside a trend toward decreased FBG and PPBG. No serious adverse effects were reported, indicating good tolerance of probiotics. These findings suggest that probiotics may positively influence metabolic parameters in T2DM patients, supporting their potential as a complementary dietary intervention. Further research is needed to understand the underlying mechanisms and enhance probiotic formulations for diabetic control.

Schlagwörter

Stichwörter der Autor:innen

HbA1cglycemic controlmetabolic healthprobioticstype 2 diabetes

Autor:innen und Institutionen

  • Department of Microbiology, SRM Medical College Hospital and Research Centre, SRMIST, Kattankulathur, Chengalapattu 603203, Tamil Nadu, India.
  • Department of General Medicine, SRM Medical College Hospital and Research Centre, SRMIST, Kattankulathur, Chengalapattu 603203, Tamil Nadu, India.
  • Department of Medical Laboratory Technology, SRM Medical College Hospital and Research Centre, SRMIST, Kattankulathur, Chengalapattu 603203, Tamil Nadu, India.

ORCID-Profile: Venkata Chaithanya, Janardanan Kumar

Förderung

  • SRM University
  • SRM Selective Excellence Research Initiative

Zitieren

APA

Chaithanya, V., Kumar, J., Vajravelu Leela, K., Ram, M., & Thulukanam, J. (2024). Impact of Multistrain Probiotic Supplementation on Glycemic Control in Type 2 Diabetes Mellitus—Randomized Controlled Trial. Life, 14(11), 1484. https://doi.org/10.3390/life14111484

Vancouver

Chaithanya V, Kumar J, Vajravelu Leela K, Ram M, Thulukanam J. Impact of Multistrain Probiotic Supplementation on Glycemic Control in Type 2 Diabetes Mellitus—Randomized Controlled Trial. Life. 2024;14(11):1484. doi:10.3390/life14111484

BibTeX
@article{Chaithanya2024,
  author = {Chaithanya, Venkata and Kumar, Janardanan and Vajravelu Leela, Kakithakara and Ram, Mohan and Thulukanam, Jayaprakash},
  title = {Impact of Multistrain Probiotic Supplementation on Glycemic Control in Type 2 Diabetes Mellitus—Randomized Controlled Trial},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {1484},
  doi = {10.3390/life14111484}
}
Kostenlos starten →